Literature DB >> 25997653

A dose response randomised controlled trial of docosahexaenoic acid (DHA) in preterm infants.

C T Collins1, T R Sullivan2, A J McPhee3, M J Stark4, M Makrides1, R A Gibson5.   

Abstract

Thirty one infants born less than 30 weeks׳ gestational age were randomised to receive either 40 (n=11), 80 (n=9) or 120 (n=11) mg/kg/day of docosahexaenoic acid (DHA) respectively as an emulsion, via the feeding tube, commenced within 4 days of the first enteral feed. Twenty three infants were enroled in non-randomised reference groups; n=11 who had no supplementary DHA and n=12 who had maternal DHA supplementation. All levels of DHA in the emulsion were well tolerated with no effect on number of days of interrupted feeds or days to full enteral feeds. DHA levels in diets were directly related to blood DHA levels but were unrelated to arachidonic acid (AA) levels. All randomised groups and the maternal supplementation reference group prevented the drop in DHA levels at study end that was evident in infants not receiving supplementation. Australian New Zealand Clinical Trials Registry: ACTRN12610000382077.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Docosahexaenoic acid; Dose response; Infant; Long chain polyunsaturated fatty acid; Premature

Mesh:

Substances:

Year:  2015        PMID: 25997653     DOI: 10.1016/j.plefa.2015.04.003

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  15 in total

1.  Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.

Authors:  Isabelle Marc; Bruno Piedboeuf; Thierry Lacaze-Masmonteil; William Fraser; Benoît Mâsse; Ibrahim Mohamed; Mosarrat Qureshi; Jehier Afifi; Brigitte Lemyre; Georges Caouette; Julie Bartholomew; Anne Monique Nuyt; Pierre Julien; Anne Synnes; Michel Lucas; Thérèse Perreault; Lannae Strueby; Zenon Cieslak; Kamran Yusuf; Gustavo Pelligra; Edith Massé; Bodil Larsen; Cecilia de Cabo; Chelsea Ruth; Faiza Khurshid; Pascal M Lavoie
Journal:  JAMA       Date:  2020-07-14       Impact factor: 56.272

2.  Early Enteral Administration of a Complex Lipid Emulsion Supplement Prevents Postnatal Deficits in Docosahexaenoic and Arachidonic Acids and Increases Tissue Accretion of Lipophilic Nutrients in Preterm Piglets.

Authors:  Olajumoke Akinsulire; George Perides; Lorenzo Anez-Bustillos; Joanne Cluette-Brown; Arthur Nedder; Elizabeth Pollack; Pratibha Singh; Yan Liu; Lady Leidy Sanchez-Fernandez; Evelyn Obregon; Ece Bicak; Savanna Kiefer; William Yakah; Hilda V Gutierrez; Duy T Dao; Mustafa Vurma; Stefan Ehling; Douglas Gordon; Stephen DeMichele; Steven D Freedman; Camilia R Martin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-08-23       Impact factor: 4.016

Review 3.  Neuroprotection Strategies in Preterm Encephalopathy.

Authors:  Pratik Parikh; Sandra E Juul
Journal:  Semin Pediatr Neurol       Date:  2019-08-09       Impact factor: 1.636

Review 4.  Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Authors:  Gregory Guthrie; Muralidhar Premkumar; Douglas G Burrin
Journal:  Nutr Clin Pract       Date:  2017-01-27       Impact factor: 3.080

Review 5.  Lipids and Long Chain Polyunsaturated Fatty Acids in Preterm Infants.

Authors:  Kristin Santoro; Camilia R Martin
Journal:  Clin Perinatol       Date:  2022-04-21       Impact factor: 2.642

6.  Daily Enteral DHA Supplementation Alleviates Deficiency in Premature Infants.

Authors:  Michelle L Baack; Susan E Puumala; Stephen E Messier; Deborah K Pritchett; William S Harris
Journal:  Lipids       Date:  2016-02-04       Impact factor: 1.880

7.  Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS).

Authors:  Mireille Guillot; Carole-Anne Robitaille; Laurence Turner; Etienne Pronovost; Georges Caouette; Célia Matte-Gagné; François Olivier; Julie Bartholomew; Édith Massé; Alyssa Morin; Ibrahim Mohamed; Isabelle Marc
Journal:  BMJ Open       Date:  2022-05-04       Impact factor: 3.006

Review 8.  Docosahexaenoic acid and the preterm infant.

Authors:  Stephanie L Smith; Christopher A Rouse
Journal:  Matern Health Neonatol Perinatol       Date:  2017-12-12

9.  The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.

Authors:  Carmel T Collins; Robert A Gibson; Maria Makrides; Andrew J McPhee; Thomas R Sullivan; Peter G Davis; Marta Thio; Karen Simmer; Victor S Rajadurai
Journal:  BMC Pediatr       Date:  2016-06-01       Impact factor: 2.125

10.  Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial.

Authors:  Svetlana Najm; Chatarina Löfqvist; Gunnel Hellgren; Eva Engström; Pia Lundgren; Anna-Lena Hård; Alexandre Lapillonne; Karin Sävman; Anders K Nilsson; Mats X Andersson; Lois E H Smith; Ann Hellström
Journal:  Clin Nutr ESPEN       Date:  2017-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.